Monitor conversion terms and future financing needs; while the cash infusion supports operations, the discount pricing and convertibility suggest financial pressure and could lead to shareholder dilution. Evaluate against the company's $2M market cap as a significant capital structure event.
Price Chart
Executive Summary
Clearmind Medicine Inc. announced the issuance of $1.75 million in convertible promissory notes at a 10% discount, receiving $1.575 million in proceeds. This is part of a previously disclosed $10 million funding facility. The transaction provides near-term liquidity but increases future dilution risk if notes convert to equity.
Key Facts
- Issued convertible promissory notes with aggregate principal of $1,750,000
- Received $1,575,000 in cash (90% of principal amount)
- Transaction occurred on April 14, 2026
- Part of a larger $10 million securities purchase agreement established September 17, 2025
- Notes are convertible, creating potential future share dilution
Financial Impact
$1.575 million in immediate cash proceeds with potential for 10% dilution upon conversion
Risk Factors
- Potential share dilution if notes convert to equity
- Future financial covenants or conversion terms not disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-043518 |
| Document: 0001213900-26-043518-index-headers.html | 0001213900-26-043518 |
| Document: 0001213900-26-043518-index.html | 0001213900-26-043518 |
| Document: 0001213900-26-043518.txt | 0001213900-26-043518 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $6.12 (−2.02%) |
Oct 13, 2026 13d ago | 6-K | $6.23 | awaiting T+60 | — | $6.12 (−1.75%) |
Oct 8, 2026 18d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.26%) |
Oct 7, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.26%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $6.12 (+620.12%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $6.12 (+620.12%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $6.12 (−10.82%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $6.12 (+548.41%) |
Sep 8, 2026 6w ago | 6-K | $1.03 | awaiting T+60 | — | $6.12 (+494.27%) |
Sep 4, 2026 7w ago | 6-K | $1.16 | awaiting T+60 | — | $6.12 (−427.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers